De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 von Curigliano, G, Burstein, H.J., Winer, E.P., Gnant, M., Dubsky, P., Loibl, S., Colleoni, M., Regan, M.M., Piccart-Gebhart, M., Senn, H.-J., Thürlimann, B., André, F., Baselga, J., Bergh, J., Bonnefoi, H., Brucker, S.Y., Cardoso, F., Carey, L., Ciruelos, E., Cuzick, J., Denkert, C., Di Leo, A., Ejlertsen, B., Francis, P., Galimberti, V., Garber, J., Gulluoglu, B., Goodwin, P., Harbeck, N., Hayes, D.F., Huang, C.-S., Huober, J., Khaled, H., Jassem, J., Jiang, Z., Karlsson, P., Morrow, M., Orecchia, R., Osborne, K.C., Pagani, O., Partridge, A.H., Pritchard, K., Ro, J., Rutgers, E.J.T., Sedlmayer, F., Semiglazov, V., Shao, Z., Smith, I., Toi, M., Tutt, A., Viale, G., Watanabe, T., Whelan, T.J., Xu, B.

Volltext

Plasma Letrozole Concentrations in Postmenopausal Women With Breast Cancer Are Associated With CYP2A6 Genetic Variants, Body Mass Index, and Age von Desta, Z, Kreutz, Y, Nguyen, A T, Li, L, Skaar, T, Kamdem, L K, Henry, N L, Hayes, D F, Storniolo, A M, Stearns, V, Hoffmann, E, Tyndale, R F, Flockhart, D A

Volltext

Elevated S100A8 protein expression in breast cancer cells and breast tumor stroma is prognostic of poor disease outcome von Miller, P., Kidwell, K. M., Thomas, D., Sabel, M., Rae, J. M., Hayes, D. F., Hudson, B. I., El-Ashry, D., Lippman, M. E.

Volltext

The measurement and therapeutic implications of circulating tumour cells in breast cancer von SMERAGE, J. B, HAYES, D. F

Volltext

The Pharmacogenetics Research Network: From SNP Discovery to Clinical Drug Response von Giacomini, K M, Brett, C M, Altman, R B, Benowitz, N L, Dolan, M E, Flockhart, D A, Johnson, J A, Hayes, D F, Klein, T, Krauss, R M, Kroetz, D L, McLeod, H L, Nguyen, A T, Ratain, M J, Relling, M V, Reus, V, Roden, D M, Schaefer, C A, Shuldiner, A R, Skaar, T, Tantisira, K, Tyndale, R F, Wang, L, Weinshilboum, R M, Weiss, S T, Zineh, I

Volltext

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 von Curigliano, G, Burstein, H J, Winer, E P, Gnant, M, Dubsky, P, Loibl, S, Colleoni, M, Regan, M M, Piccart-Gebhart, M, Senn, H -J, Thürlimann, B, André, F, Baselga, J, Bergh, J, Bonnefoi, H, Brucker, S Y, Cardoso, F, Carey, L, Ciruelos, E, Cuzick, J, Denkert, C, Di Leo, A, Ejlertsen, B, Francis, P, Galimberti, V, Garber, J, Gulluoglu, B, Goodwin, P, Harbeck, N, Hayes, D F, Huang, C -S, Huober, J, Khaled, H, Jassem, J, Jiang, Z, Karlsson, P, Morrow, M, Orecchia, R, Osborne, K C, Pagani, O, Partridge, A H, Pritchard, K, Ro, J, Rutgers, E J T, Sedlmayer, F, Semiglazov, V, Shao, Z, Smith, I, Toi, M, Tutt, A, Viale, G, Watanabe, T, Whelan, T J, Xu, B

Volltext

Predictors of recovery of ovarian function during aromatase inhibitor therapy von Henry, N.L., Xia, R., Banerjee, M., Gersch, C., McConnell, D., Giacherio, D., Schott, A.F., Pearlman, M., Stearns, V., Partridge, A.H., Hayes, D.F.

Volltext

Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers von Simon, Richard M., Paik, Soonmyung, Hayes, Daniel F.

Volltext

CYP2D6 Genotype, Antidepressant Use, and Tamoxifen Metabolism During Adjuvant Breast Cancer Treatment von Jin, Yan, Desta, Zeruesenay, Stearns, Vered, Ward, Bryan, Ho, Herbert, Lee, Kyung-Hoon, Skaar, Todd, Storniolo, Anna Maria, Li, Lang, Araba, Adjei, Blanchard, Rebecca, Nguyen, Anne, Ullmer, Lynda, Hayden, Jill, Lemler, Suzanne, Weinshilboum, Richard M., Rae, James M., Hayes, Daniel F., Flockhart, David A.

Volltext

When Is a Tumor Marker Ready for Prime Time? A Case Study of c-erbB-2 as a Predictive Factor in Breast Cancer von YAMAUCHI, Hideko, STEARNS, Vered, HAYES, Daniel F

Volltext

2000 Update of Recommendations for the Use of Tumor Markers in Breast and Colorectal Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology von BAST, Robert C, RAVDIN, Peter, HAYES, Daniel F, BATES, Susan, FRITSCHE, Herbert JR, JESSUP, John M, KEMENY, Nancy, LOCKER, Gershon Y, MENNEL, Robert G, SOMMERFIELD, Mark R

Volltext

Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group von Dowsett, Mitch, Nielsen, Torsten O., A'Hern, Roger, Bartlett, John, Coombes, R. Charles, Cuzick, Jack, Ellis, Matthew, Henry, N. Lynn, Hugh, Judith C., Lively, Tracy, McShane, Lisa, Paik, Soon, Penault-Llorca, Frederique, Prudkin, Ljudmila, Regan, Meredith, Salter, Janine, Sotiriou, Christos, Smith, Ian E., Viale, Giuseppe, Zujewski, Jo Anne, Hayes, Daniel F.

Volltext

Circulating tumour cells: insights into tumour heterogeneity von Hayes, D. F., Paoletti, C.

Volltext

Cytochrome P450 2D6 activity predicts discontinuation of tamoxifen therapy in breast cancer patients von Rae, J M, Sikora, M J, Henry, N L, Li, L, Kim, S, Oesterreich, S, Skaar, T C, Nguyen, A T, Desta, Z, Storniolo, A M, Flockhart, D A, Hayes, D F, Stearns, V

Volltext

Aromatase inhibitor-induced modulation of breast density: clinical and genetic effects von Henry, N L, Chan, H-P, Dantzer, J, Goswami, C P, Li, L, Skaar, T C, Rae, J M, Desta, Z, Khouri, N, Pinsky, R, Oesterreich, S, Zhou, C, Hadjiiski, L, Philips, S, Robarge, J, Nguyen, A T, Storniolo, A M, Flockhart, D A, Hayes, D F, Helvie, M A, Stearns, V

Volltext

A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil®) in controlling hot flashes in breast cancer survivors von Stearns, V., Isaacs, C., Rowland, J., Crawford, J., Ellis, M. J., Kramer, R., Lawrence, W., Hanfelt, J.J., Hayes, D.F.

Volltext

A phase I trial of a Bcl-2 antisense (G3139) and weekly docetaxel in patients with advanced breast cancer and other solid tumors von Marshall, J., Chen, H., Yang, D., Figueira, M., Bouker, K. B., Ling, Y., Lippman, M., Frankel, S. R., Hayes, D. F.

Volltext

Reply to ‘The St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: the point of view of an International Panel of Experts in Radiation Oncol... von Dubsky, P., Curigliano, G., Burstein, H.J., Winer, E.P., Gnant, M., Loibl, S., Colleoni, M., Regan, M.M., Piccart-Gebhart, M., Senn, H.-J., Thürlimann, B., André, F., Baselga, J., Bergh, J., Bonnefoi, H., Brucker, S.Y., Cardoso, F., Carey, L., Ciruelos, E., Cuzick, J., Denkert, C., Di Leo, A., Ejlertsen, B., Francis, P., Galimberti, V., Garber, J., Gulluoglu, B., Goodwin, P., Harbeck, N., Hayes, D.F., Huang, C.-S., Huober, J., Khaled, H., Jassem, J., Jiang, Z., Karlsson, P., Morrow, M., Orecchia, R., Osborne, K.C., Pagani, O., Partridge, A.H., Pritchard, K., Ro, J., Rutgers, E.J.T., Sedlmayer, F., Semiglazov, V., Shao, Z., Smith, I., Toi, M., Tutt, A., Viale, G., Watanabe, T., Whelan, T.J., Xu, B.

Volltext

Risk-adapted modulation through de-intensification of cancer treatments: an ESMO classification von Trapani, D., Franzoi, M.A., Burstein, H.J., Carey, L.A., Delaloge, S., Harbeck, N., Hayes, D.F., Kalinsky, K., Pusztai, L., Regan, M.M., Sestak, I., Spanic, T., Sparano, J., Jezdic, S., Cherny, N., Curigliano, G., Andre, F.

Volltext

Impact of homologous recombination deficiency biomarkers on outcomes in patients with triple-negative breast cancer treated with adjuvant doxorubicin and cyclophosphamide (SWOG S93... von Sharma, P., Barlow, W.E., Godwin, A.K., Pathak, H., Isakova, K., Williams, D., Timms, K.M., Hartman, A.R., Wenstrup, R.J., Linden, H.M., Tripathy, D., Hortobagyi, G.N., Hayes, D.F.

Volltext